1. Pretransplant interferon-γ secretion by CMV-specific CD8+ T cells informs the risk of CMV replication after transplantation
- Author
-
J. Redel, Sara Cantisán, L. Bueno, Juan Gutiérrez-Aroca, Julián Torre-Cisneros, Rosario Lara, Antonio Rivero, Alberto Rodríguez-Benot, Rafael Solana, Marcelino González-Padilla, and Miguel Montejo
- Subjects
Adult ,Graft Rejection ,Male ,Congenital cytomegalovirus infection ,Cytomegalovirus ,CD8-Positive T-Lymphocytes ,Antiviral Agents ,Virus ,Interferon-gamma ,Young Adult ,Interferon ,Risk Factors ,medicine ,Immunology and Allergy ,Cytotoxic T cell ,Humans ,Pharmacology (medical) ,Longitudinal Studies ,Prospective cohort study ,Aged ,Transplantation ,Lung ,business.industry ,Middle Aged ,medicine.disease ,Prognosis ,Kidney Transplantation ,medicine.anatomical_structure ,Immunology ,Cytomegalovirus Infections ,Female ,business ,CD8 ,Biomarkers ,medicine.drug ,Lung Transplantation - Abstract
In this prospective study we analyzed pretransplant interferon-γ secretion by cytomegalovirus (CMV)-specific CD8+ T cells to assess its possible utility in determining the risk of CMV replication after solid organ transplantation. A total of 113 lung and kidney transplant patients were enrolled in the study but only 55 were evaluable. All CMV-seronegative recipients were pretransplant "nonreactive" (IFNγ
- Published
- 2012